A. Dekker

1.8k total citations
38 papers, 1.3k citations indexed

About

A. Dekker is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Dekker has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 27 papers in Otorhinolaryngology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Dekker's work include Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Diagnosis and Treatment (11 papers). A. Dekker is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Diagnosis and Treatment (11 papers). A. Dekker collaborates with scholars based in United States, United Kingdom and Canada. A. Dekker's co-authors include Everett E. Vokes, Ezra E.W. Cohen, Tanguy Y. Seiwert, Kerstin Stenson, Theodore Karrison, Daniel J. Haraf, Elizabeth A. Blair, Ann M. Mauer, Carolyn Pierce and Mark Kozloff and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

A. Dekker

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Dekker United States	17	710	638	551	410	314	38	1.3k
J-P. Machiels Belgium	17	676 1.0×	304 0.5×	432 0.8×	226 0.6×	419 1.3×	53	1.2k
Steven E. Vogl United States	21	749 1.1×	250 0.4×	554 1.0×	229 0.6×	458 1.5×	55	1.4k
Timothy Aliff United States	8	908 1.3×	169 0.3×	1.0k 1.8×	282 0.7×	140 0.4×	8	1.6k
Asawari Patil India	16	380 0.5×	212 0.3×	224 0.4×	196 0.5×	284 0.9×	88	927
Tran‐Der Tan Taiwan	13	371 0.5×	426 0.7×	166 0.3×	90 0.2×	340 1.1×	37	799
A A Forastiere United States	9	911 1.3×	1.5k 2.4×	605 1.1×	232 0.6×	1.1k 3.7×	14	2.0k
M. Frikha Tunisia	13	398 0.6×	294 0.5×	175 0.3×	110 0.3×	250 0.8×	71	724
Roger K.C. Ngan China	18	945 1.3×	1.1k 1.7×	491 0.9×	235 0.6×	826 2.6×	43	2.1k
Avi B. Markowitz United States	16	561 0.8×	97 0.2×	383 0.7×	245 0.6×	377 1.2×	35	1.1k
Padmini Giri United States	6	911 1.3×	1.4k 2.3×	590 1.1×	195 0.5×	1.1k 3.4×	11	1.9k

Countries citing papers authored by A. Dekker

Since Specialization

Citations

This map shows the geographic impact of A. Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dekker more than expected).

Fields of papers citing papers by A. Dekker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dekker. The network helps show where A. Dekker may publish in the future.

Co-authorship network of co-authors of A. Dekker

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dekker. A scholar is included among the top collaborators of A. Dekker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dekker. A. Dekker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dekker, A., et al.. (2025). Donor‐Related Risk Factors for Normothermic Machine Perfusion in Liver Transplantation: A Meta‐Analysis. Liver International. 45(6). e70116–e70116. 1 indexed citations

Brisson, Ryan J., Sara Kochanny, Saba Arshad, et al.. (2019). A pilot study of the pan‐class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer. Head & Neck. 41(11). 3842–3849. 22 indexed citations

Seiwert, Tanguy Y., Corey C. Foster, Elizabeth A. Blair, et al.. (2018). OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer. Annals of Oncology. 30(2). 297–302. 149 indexed citations

Kochanny, Sara, Corey C. Foster, Arun Khattri, et al.. (2018). Association of low serum albumin concentration with reduced overall survival for patients with metastatic head and neck cancer receiving anti-programmed death receptor-1 therapy.. Journal of Clinical Oncology. 36(15_suppl). 6057–6057.

Melotek, J.M., Tanguy Y. Seiwert, Elizabeth A. Blair, et al.. (2017). Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.. Journal of Clinical Oncology. 35(15_suppl). 6066–6066. 9 indexed citations

Brisson, Ryan J., A. Dekker, Jonas A. de Souza, et al.. (2017). A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent/metastatic head and neck cancer.. Journal of Clinical Oncology. 35(15_suppl). 6039–6039. 2 indexed citations

Seiwert, Tanguy Y., J.M. Melotek, Elizabeth A. Blair, et al.. (2016). Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(1). 21–29. 27 indexed citations

Perez, Cesar A., Luis E. Raez, Mark Agulnik, et al.. (2012). Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncology. 48(9). 887–892. 37 indexed citations

Villaflor, Victoria, Daniel J. Haraf, Joseph K. Salama, et al.. (2011). Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Annals of Oncology. 22(11). 2501–2507. 16 indexed citations

10.

Cohen, Ezra E.W., Daniel J. Haraf, Rangesh Kunnavakkam, et al.. (2010). Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(20). 3336–3343. 64 indexed citations

11.

Choong, Nicholas W., Mark Kozloff, David Taber, et al.. (2009). Phase II study of sunitinib malate in head and neck squamous cell carcinoma. Investigational New Drugs. 28(5). 677–683. 59 indexed citations

12.

Sung, Lillian, Upton Allen, Ahmed Naqvi, et al.. (2007). EFFICACY AND SAFETY OF CASPOFUNGIN FOR THE EMPIRIC MANAGEMENT OF FEVER IN NEUTROPENIC CHILDREN. The Pediatric Infectious Disease Journal. 26(9). 854–856. 15 indexed citations

13.

Seiwert, Tanguy Y., Ezra E.W. Cohen, Daniel J. Haraf, et al.. (2007). A Phase I Trial of Docetaxel Based Induction and Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer. Cancer Investigation. 25(6). 435–444. 7 indexed citations

14.

Seto, Winnie, A. Dekker, Eshetu G. Atenafu, et al.. (2007). Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 59(6). 1135–1140. 19 indexed citations

15.

Seiwert, Tanguy Y., Darren W. Davis, Dongyao Yan, et al.. (2007). pKDR/KDR ratio predicts response in a phase I/II pharmacodynamic study of erlotinib and bevacizumab for recurrent or metastatic head and neck cancer (HNC). Journal of Clinical Oncology. 25(18_suppl). 6021–6021. 11 indexed citations

16.

Bosmans, Guy, et al.. (2006). Subvolume boosting of FDG-positive tumour areas in patients with non-small cell lung cancer (NSCLC): A planning study using IMRT. Radiotherapy and Oncology. 81. 1 indexed citations

17.

Dekker, A., et al.. (2006). Meta-Analysis of Randomized Controlled Trials of Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor After Autologous and Allogeneic Stem Cell Transplantation. Journal of Clinical Oncology. 24(33). 5207–5215. 71 indexed citations

18.

Salama, Joseph K., Kerstin Stenson, Ezra E.W. Cohen, et al.. (2006). 24. International Journal of Radiation Oncology*Biology*Physics. 66(3). S14–S14. 5 indexed citations

19.

Milano, Michael T., Everett E. Vokes, Johnny Kao, et al.. (2006). Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. International Journal of Oncology. 28(5). 1141–51. 22 indexed citations

20.

Vokes, Everett E., Ezra E.W. Cohen, Ann M. Mauer, et al.. (2005). A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC). Journal of Clinical Oncology. 23(16_suppl). 5504–5504. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact